Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva halts output at U.S. drug plant after FDA flags concerns | Reuters")
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
Teva says it's in talks with COVID vaccine makers to help produce shots | The Times of Israel
Teva Recalls U.S.-Made Drugs Following Contamination Fears
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/7333YBOGCNAO7EPBSMO24XX7BA.jpg "Teva Pharmaceuticals to narrow focus on drugs, trim costs")
Teva Pharmaceuticals to narrow focus on drugs, trim costs
Teva Canada (@TevaCanadaLtd) / Twitter
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Novartis, Mylan and Teva to supply tens of millions of chloroquine tablets to fight COVID-19 | FiercePharma
Teva plans 'risky' price rise on US medicines | Financial Times
Teva looks to plug gap in its biomanufacturing network
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Teva Pharmaceuticals - Wikipedia
Teva Recalls U.S.-Made Drugs Following Contamination Fears (3)
Drugmaker to pay $1.2 billion to settle 'pay for delay' lawsuit | PBS NewsHour
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
Anything but Generic: A map for Selling to Teva Pharmaceuticals
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Israeli drugmaker Teva to cut quarter of global work force | AP News
Taiyo Pharmaceutical Industry, Contract Manufacturing Plant - Pharmaceutical Technology
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals to slash 14,000 jobs and suspend its dividend
There May Be a Silver Lining to Teva's Woes | Ctech
Teva plans the large-scale production of monoclonal antibodies in Ulm - Healthcare industry
Drugmaker Teva makes $40B bid for rival Mylan
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
Teva Recalls U.S.-Made Drugs Following Contamination Fears - Bloomberg
